Introduction: In individual placebo-controlled trials in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF), treatment with nintedanib was associated with numerical reductions in mortality.
No takes yet. Share an insight, caveat, or question.
Koschel et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: